ArrowMark Colorado Holdings Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globus Medical
GMED
|
+$43.4M |
| 2 |
First American
FAF
|
+$40.2M |
| 3 |
Federal Signal
FSS
|
+$28.2M |
| 4 |
JBTM
JBT Marel
JBTM
|
+$27.5M |
| 5 |
nCino
NCNO
|
+$26.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACV Auctions
ACVA
|
+$111M |
| 2 |
Matsons
MATX
|
+$83.2M |
| 3 |
Graphic Packaging
GPK
|
+$55M |
| 4 |
SKX
Skechers
SKX
|
+$53.3M |
| 5 |
RB Global
RBA
|
+$50.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.95% |
| 2 | Technology | 24.06% |
| 3 | Industrials | 16.17% |
| 4 | Consumer Discretionary | 13.61% |
| 5 | Communication Services | 5.16% |
Similar funds
ArrowMark Colorado Holdings's Q3 2024 Portfolio in Review
As of Q3 2024, ArrowMark Colorado Holdings held 338 positions worth $7.81B, down 6.9% from $8.39B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ArrowMark Colorado Holdings withdrew a net $1.14B in Q3 2024, closing 37 positions and reducing 121 holdings. Its most notable exit was National Vision, an estimated $31.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.
Against the trend, ArrowMark Colorado Holdings opened a new position in Globus Medical worth $43.9M.
- ArrowMark Colorado Holdings's largest Q3 2024 buy was Globus Medical: 614,295 shares worth $43.9M.
- ArrowMark Colorado Holdings added most to nCino in Q3 2024, an estimated $26.2M increase.
- ArrowMark Colorado Holdings's biggest Q3 2024 reduction was ACV Auctions, cutting an estimated $111M.
- ArrowMark Colorado Holdings fully exited National Vision in Q3 2024, selling an estimated $31.5M.
- ArrowMark Colorado Holdings's ten largest holdings make up 23% of its $7.81B portfolio in Q3 2024.
- ArrowMark Colorado Holdings opened 26 new positions and closed 37 in Q3 2024.
- ArrowMark Colorado Holdings's portfolio value fell 6.9% quarter-over-quarter to $7.81B.
Based on ArrowMark Colorado Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.